New eye injection aims to save sight in diabetes patients
NCT ID NCT05802329
First seen Jun 26, 2026 · Last updated Jul 31, 2026 · Updated 2 times
Summary
This early-stage trial tests a new drug called OCU200, given as an injection into the eye, for people with diabetic macular edema (swelling in the center of the retina caused by diabetes). The study will include 24 participants and will primarily check for safety and side effects, while also measuring vision changes. The goal is to see if OCU200 can help control the condition and preserve eyesight.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- OCU200 (injected into the eye)
- What this could lead to
- If it works, this could point toward a new treatment to control vision loss from diabetic macular edema.
- What could go wrong
- This is a very early, small Phase 1 trial focused on safety, not proof of effectiveness. The treatment may not improve vision or could cause side effects like eye pain or infection.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CENTER INVOLVED DIABETIC MACULAR EDEMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Advanced Research LLC
RECRUITINGDeerfield Beach, Florida, 33064, United States
-
Erie Retina Research, LLC
RECRUITINGErie, Pennsylvania, 16507, United States
-
Gundersen Health System
RECRUITINGLa Crosse, Wisconsin, 54601, United States
-
Retina Consultants of America
RECRUITINGSouthlake, Texas, 76092, United States
-
Retina Consultants of Texas Research Centers
RECRUITINGBellaire, Texas, 77401, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new eye injection preserve vision in south asians with diabetes?
- Can a One-Time gene therapy offer lasting protection for diabetic retinopathy?
- Could a biosimilar eye injection offer a new way to treat diabetic macular edema?
- Can a steroid implant boost the effect of standard eye injections for hard-to-treat diabetic macular edema?
- Eye injection aims to tame leading causes of blindness
- New eye drug aims to restore vision in Diabetes-Related swelling